WD
Publicaties op Oncologisch.com
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovar...
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer ...
Nab-paclitaxel verbetert DFS bij vroeg mammacarcinoom: GBG 69/GeparSepto
TILs, PD-1 en PD-L1 bij klierpositief HER2-positief mammacarcinoom